Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 396 participants.
Also called NCT06520904
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 396 participants
- Registry
-
NCT06520904
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06520904. Randomized; no masking; primary purpose treatment. Start 2024-07-01 (actual); primary completion 2026-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography
- Condition
- Coronary Artery Disease
- Condition
- Optical Coherence Tomography
- Intervention (Drug)
- PCSK9 inhibitor
- Intervention (Drug)
- Statin
- Lead sponsor
- First Affiliated Hospital of Xinjiang Medical University
Record details
- Record id
cardio:ct-nct06520904- Content hash
c327d2399116e9eca7cc529b4c458adc69078161970ecbc9c0669ad693f21fbf